ImmunityBio, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2013 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
ImmunityBio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2023.
- ImmunityBio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$85.7M, a 10.3% increase year-over-year.
- ImmunityBio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$588M, a 28.3% decline year-over-year.
- ImmunityBio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$583M, a 40% decline from 2022.
- ImmunityBio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$417M, a 20.1% decline from 2021.
- ImmunityBio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$347M, a 56.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)